1. Food and Drug Administration. Magnetic resonance diagnostic device: panel recommendation and report on petitions for MR reclassification. Federal Register 1988; 53: 7575–7579.
2. Food and Drug Administration. Guidance for the submission of premarket notifications for magnetic resonance diagnostic devices: operating mode limits for RF power. In Rockville, Md: U.S. Department of Health and Human Services, Food and Drug Administration; 1998.
3. Whitby EH, Paley MN, Smith MF et al. Low field strength magnetic resonance imaging of the neonatal brain. Arch Dis Child Fetal Neonatal Ed 2003; 88: F203–F208.
4. Hall AS, Young IR, Davies FGA, Mohapatra SN. A dedicated MR system in a neonatal intensive therapy unit. In Bradley WG, Bydder GM, eds. Advanced MR Imaging Techniques. London: Martin Dunitz; 1997. p. 281–289.
5. Bluml S, Friedlich P, Wood JC et al. MR imaging of newborns by using an MR-compatible incubator with integrated radiofrequency coils: Initial experience. Radiology 2004; 231(2): 594–601.